Two Sigma Investments’s Werewolf Therapeutics HOWL Stock Holding History
Bought
Maintained
Sold
Other funds holding HOWL
RCM
LCM
SFM
DF
VA
Two Sigma Investments's HOWL Position: Q2 2026 in Review
Two Sigma Investments opened a new position in Werewolf Therapeutics (HOWL) in Q2 2026: 27,300 shares worth $9.82K. The stake represents ﹤0.01% of the portfolio and ranks #5005 among its holdings. This is a return to the name: Two Sigma Investments previously reported a position in HOWL as recently as Q3 2025.
Two Sigma Investments first reported a position in HOWL in Q4 2021 and has held it in 14 quarters since. The position peaked at $1.2M in Q1 2024. 45 funds tracked by Wall St. Rank hold HOWL as of Q2 2026.
- Two Sigma Investments held 27,300 shares of Werewolf Therapeutics worth $9.82K as of Q2 2026.
- Werewolf Therapeutics was a new Two Sigma Investments position in Q2 2026.
- Werewolf Therapeutics made up ﹤0.01% of Two Sigma Investments's portfolio in Q2 2026, its #5005 holding.
- Two Sigma Investments first reported a position in Werewolf Therapeutics in Q4 2021 and has held it in 14 quarters since.
- Two Sigma Investments's Werewolf Therapeutics position peaked at $1.2M in Q1 2024.
- 45 funds tracked by Wall St. Rank held Werewolf Therapeutics as of Q2 2026.
Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.